![](https://sygnaturazdrowia.pl/wp-content/uploads/2023/05/clock-with-pepper-blue-background-top-view-potency-problem-concept-780x470.jpg)
PremiumWitamina B3Zdrowie mężczyzn
Zaburzenia erekcji i niacyna
Treść, którą próbujesz wyświetlić, jest dostępna tylko dla członków naszej witryny. Jeśli masz już członkostwo, musisz się zalogować, aby je zobaczyć. Kliknij ten link, jeśli chcesz się zarejestrować .
Already a member? Log in here
Źródło
1. Ng C-F, Lee C-P, Ho AL, et al. (2011) Effect of niacin on erectile function in men suffering erectile dysfunction and dyslipidemia. J Sex Med. 8:2883-2893. 2. Hoffer A, Saul AW, Foster HD (2015) Niacin: The Real Story. Basic Health Pubs. ISBN-13: 978-1591202752.3. Parsons W (2000) Cholesterol Control Without Diet. Lilac Press. ISBN-13: 978-09662568714. Nehra A, Jackson G, Miner M, et al. (2012) The Princeton III Consensus Recommendations for the Management of Erectile Dysfunction and Cardiovascular Disease. Mayo Clin Proc 87:766-7785. Miner M, Seftel AD, Nehra A, et al. (2012) Prognostic utility of erectile dysfunction for cardiovascular disease in younger men and those with diabetes. Am Heart J. 164:21-28.6. Carlson LA (2005) Nicotinic acid: the broad-spectrum lipid drug. A 50th anniversary review. J Intern Med. 258:94-114.7. Creider JC, Hegele RA, Joy TR (2012) Niacin: another look at an underutilized lipid-lowering medication. Nat Rev Endocrinol. 8:517-528. 8. Guyton JR, Bays HE (2007) Safety considerations with niacin therapy. Am J Cardiol. 99:22C-31C9.Pieper JA (2002) Understanding niacin formulations. Am J Manag Care 8:S308-S31410. Canner PL, Berge KG, Wenger NK, et al. (1986) Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin. J Am Coll Cardiol. 8:1245-1255.11. Kelly LE, Ohlsson A, Shah PS. (2017) Sildenafil for pulmonary hypertension in neonates. Cochrane Database Syst Rev. 8:CD00549412.Wang R, Jiang F, Zheng Q, et al. (2014) Efficacy and safety of sildenafil treatment in pulmonary arterial hypertension: a systematic review. Respir Med. 108:531-537.13.Tunstall-Pedoe H, Woodward M, Tavendale R, et al. (1997) Comparison of the prediction by 27 different factors of coronary heart disease and death in men and women of the Scottish Heart Health Study: cohort study. BMJ 315:722-729.14.Jacobson TA (2013) Lipoprotein(a), cardiovascular disease, and contemporary management. Mayo Clin Proc. 88:1294-1311.